Importation Of Us Clinical Trial-labelled Remdesivir For Injection Due To Shortage Of Canadian-labelled Remdesivir

Remdesivir Recall Summary Remdesivir for injection products labelled for US clinical trials are being imported into Canada to address a shortage of Canadian-labelled remdesivir. This medication is used to treat COVID-19. The product is being distributed across Canada due to safety concerns related to the supply shortage.

Reason

COVID - Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-09-15

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7ffb1248-1ad1-4eb3-910c-4523ee38ba73